Carbatrol

Company: Elan Pharmaceuticals
Approval Status: Approved September 1997
Treatment for: anticonvulsant and trigeminal neuralgia
Areas: Neurology & Nervous System

| General Information |

General Information

Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures and trigeminal neuralgia. Carbatrol is recommended for use twice daily as an extended release drug.

< back to top

Carbatrol Drug Information

The Carbatrol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.